U.S. Markets close in 3 hrs, 19 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 9,477.77 | 90.16 | 0.96% |
| NASDAQ | 1,827.24 | -17.01 | -0.92% |
| S&P 500 | 1,014.14 | 10.79 | 1.08% |
| Day Low | 22.49 | |
|---|---|---|
| Day High | 24.64 |
|
| Range | 2.15 | |
| Volume | 819,112 | |
| 30-Day Avg. Vol. | 2.09 M |
|
| Difference | -60.96% | |
| Market Cap. | 2.29 B | |
| Change | 27.87 M | |
| Shares Out. | 99.56 M | |
| Percent Traded | 0.82% | |
| Revenue (LFY) | 121.58 M | |
| Earnings (TTM) | -15.8 M | |
| Next Earnings | 02/09/2009 |
|
| EPS (TTM) | 0.03 |
| 52-Wk Low 10/10/08 | 18.48 | |
|---|---|---|
| 52-Wk High 2/14/08 | 41.00 |
|
| Range | 22.52 | |
| Prev. Close 10/13/08 | 22.73 | |
| Today's Open | 23.70 | |
| Change | 4.27% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 1.2453 | |
| P/E Ratio (TTM) | 767.00 | |
| P/E Ratio (Fwd.) | 31.00 |
If spawning orphans makes for success in the drug world, then BioMarin Pharmaceutical takes the prize. The company has developed three FDA-approved drugs that qualify for orphan drug status, a financial ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | -0.045 3/31/08 | 0.02 3/31/08 |
0.065
Beat
|
| Last Quarter | 0.031 6/30/08 | 0.04 6/30/08 |
0.009
Beat
|
| Quarterly - 06/30/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 64.17 M | 121.58 M |
| Gross Profit | 53.49 M | 98.85 M |
| Operating Income | 4.53 M | -57.29 M |
| Net Income | 3.81 M | -15.80 M |
